Physician profile
Lindsey Hines Eason
NPI 1134507825
$3,020.80
in general payments reported to CMS, 2019-2025
39 companies · $468 in 2025
The $468 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $389 · 2021: $213 · 2022: $596 · 2023: $603 · 2024: $571 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.85 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $391.34 | 2021-2024 | Ova1 |
| Astellas Pharma US INC | $373.04 | 2019-2025 | Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $321.08 | 2019-2025 | |
| Abbvie INC. | $258.42 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $157.16 | 2021-2025 | |
| Pfizer INC. | $156.21 | 2020-2024 | |
| Sumitomo Pharma America, INC. | $142.27 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $140.81 | 2021-2025 | Novasure, Aptima, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $96.74 | 2020-2024 | Slynd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.27 | 2020-2021 | |
| Sage Therapeutics, LLC | $69.77 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $66.53 | 2020-2022 | |
| Avion Pharmaceuticals | $66.05 | 2020-2023 | Balcoltra |
| Gynesonics, INC. | $63.10 | 2023-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Radius Health, INC. | $60.64 | 2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $52.24 | 2022 | |
| Exact Sciences Corporation | $45.55 | 2023-2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $42.09 | 2022 | |
| Shield Therapeutics INC | $41.80 | 2025 | |
| Axonics, INC. | $40.09 | 2022-2023 | Axonics |
| Ethicon US, LLC | $37.65 | 2024 | Dermabond Prineo, Stratafix |
| Organon LLC | $33.55 | 2024 | |
| Millicent US INC | $33.16 | 2024-2025 | Intrarosa, Femring |
| Ortho-Clinical Diagnostics, INC. | $22.42 | 2024 | |
| Alexion Pharmaceuticals, INC. | $21.93 | 2023 | Ultomiris |
| Supernus Pharmaceuticals, INC. | $18.90 | 2025 | Qelbree |
| Baxter Healthcare | $16.93 | 2025 | Tisseel |
| Amag Pharmaceuticals, INC. | $16.88 | 2020 | |
| Roche Diagnostics Corporation | $16.84 | 2020 | |
| Arjo INC. | $15.92 | 2025 | |
| Lilly USA, LLC | $15.81 | 2025 | Zepbound |
| Lupin INC. | $15.35 | 2020 | |
| Davol INC. | $14.94 | 2025 | Arista |
| Minerva Surgical, INC | $13.81 | 2023 | |
| Conmed Corporation | $13.53 | 2024 | Airseal |
| Duchesnay USA Incorporated | $11.92 | 2020 | |
| Mylan Pharmaceuticals INC. | $11.90 | 2021 | |
| Merck Sharp & Dohme LLC | $11.78 | 2020 | |
| Coopersurgical, INC. | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Eason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.